Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-20 | 100.00 | 40.43 | 204.20¢ | 7.6 | 0.2 | +41% | 33.50¢ | 2.2% |
31-Dec-21 | 121.33 | 38.00 | 225.90¢ | 5.1 | 0.5 | +11% | 50.00¢ | 4.3% |
31-Dec-22 | 142.08 | 39.64 | 219.90¢ | 6.1 | n/a | -3% | 70.00¢ | 5.2% |
31-Dec-23 | 146.31 | 7.97 | (43.60)¢ | n/a | n/a | n/a | 56.00¢ | 4.4% |
31-Dec-24 | 183.02 | 40.54 | 91.20¢ | 10.8 | n/a | n/a | 56.00¢ | 5.7% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 191.72 | 64.06 | 113.71p | 8.4 | 0.1 | +61% | 43.27p | 0.0% |
31-Dec-26 | 193.28 | 59.83 | 107.21p | 8.9 | n/a | -6% | 43.27p | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
5 Yr High | 5 Yr Low | 5 Yr Avg | Curr / Avg | |
---|---|---|---|---|
Latest | 8.06 | 5.33 | 0.20 | 67.08 |
Find out about IFRS and how this affects the financial infomation for all UK companies.
Currency | UK Pounds |
Share Price | 952.50p |
Change Today | 27.50p |
% Change | 2.97 % |
52 Week High | 1,290.00p |
52 Week Low | 745.00p |
Volume | 5,581 |
Shares Issued | 19.21m |
Market Cap | £183.02m |
RiskGrade | 174 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 0 |
Buy | 2 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
Latest | Previous | |
---|---|---|
1st Interim | 4th Interim | |
Ex-Div | 03-Apr-25 | 21-Nov-24 |
Paid | 17-Apr-25 | 06-Dec-24 |
Amount | 14.00¢ | 14.00¢ |
Time | Volume / Share Price |
15:33 | 1,000 @ 951.00p |
16:01 | 1 @ 976.70p |
15:38 | 80 @ 930.00p |
15:35 | 29 @ 930.00p |
14:43 | 534 @ 990.00p |
Chair | John Lawson Kelly |
CEO | John Mark Learmonth |
You are here: research